{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:52:49Z","timestamp":1791251569320,"version":"4.1.0"},"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T00:00:00Z","timestamp":1365638400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003212","type":"journal-article","created":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T20:49:58Z","timestamp":1365713398000},"page":"e1003212","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Vaccination Strategies against Highly Pathogenic Arenaviruses: The Next Steps toward Clinical Trials"],"prefix":"10.1371","volume":"9","author":[{"given":"Stephan","family":"\u00d6lschl\u00e4ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Flatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.mib.2008.06.001","article-title":"Phylogeny of the genus Arenavirus","volume":"11","author":"RN Charrel","year":"2008","journal-title":"Curr Opin Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa053240","article-title":"Transmission of lymphocytic choriomeningitis virus by organ transplantation","volume":"354","author":"SA Fischer","year":"2006","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01310811","article-title":"Ribonucleic acids of Machupo and Lassa viruses","volume":"79","author":"IS Lukashevich","year":"1984","journal-title":"Arch Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/JVI.52.3.897-904.1984","article-title":"Sequencing studies of pichinde arenavirus S RNA indicate a novel coding strategy, an ambisense viral S RNA","volume":"52","author":"DD Auperin","year":"1984","journal-title":"J Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/mpev.1997.0436","article-title":"Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts","volume":"8","author":"MD Bowen","year":"1997","journal-title":"Mol Phylogenet Evol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/bmb\/ldh054","article-title":"Lessons from nosocomial viral haemorrhagic fever outbreaks","volume":"73\u201374","author":"SP Fisher-Hoch","year":"2005","journal-title":"Br Med Bull"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e1000836","DOI":"10.1371\/journal.ppat.1000836","article-title":"T cell-dependence of Lassa fever pathogenesis","volume":"6","author":"L Flatz","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1073\/pnas.1016404108","article-title":"Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3\u2032 to 5\u2032 exonuclease activity essential for immune suppression","volume":"108","author":"KM Hastie","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","first-page":"20","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"JB McCormick","year":"1986","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","article-title":"A case-control study of the clinical diagnosis and course of Lassa fever","volume":"155","author":"JB McCormick","year":"1987","journal-title":"J Infect Dis"},{"key":"ref11","first-page":"567","article-title":"Clinical and epidemiological patterns of Argentine haemorrhagic fever","volume":"52","author":"JI Maiztegui","year":"1975","journal-title":"Bull World Health Organ"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/514211","article-title":"Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group","volume":"177","author":"JI Maiztegui","year":"1998","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4161\/hv.7.6.15198","article-title":"Argentine hemorrhagic fever vaccines","volume":"7","author":"A Ambrosio","year":"2011","journal-title":"Hum Vaccin"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/IAI.44.2.528-533.1984","article-title":"Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain","volume":"44","author":"PB Jahrling","year":"1984","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.1890120203","article-title":"Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin","volume":"12","author":"PB Jahrling","year":"1983","journal-title":"J Med Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/149.3.420","article-title":"Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys","volume":"149","author":"PB Jahrling","year":"1984","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(79)92335-3","article-title":"Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome","volume":"2","author":"JI Maiztegui","year":"1979","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0140-6736(79)90659-7","article-title":"Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus","volume":"2","author":"MP Kiley","year":"1979","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3181\/00379727-119-30251","article-title":"Protection against Junin Virus by Immunization with Live Tacaribe Virus","volume":"119","author":"N Tauraso","year":"1965","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref20","first-page":"81","article-title":"Tacaribe virus infection of guinea-pig. Virus distribution, appearance of antibodies and immunity against Junin virus infection","volume":"20","author":"CE Coto","year":"1967","journal-title":"Arch Gesamte Virusforsch"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/infdis\/141.3.389","article-title":"Protection of guinea pigs inoculated with Tacaribe virus against lethal doses of Junin virus","volume":"141","author":"CE Coto","year":"1980","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/IAI.35.2.425-430.1982","article-title":"Cross-protection in nonhuman primates against Argentine hemorrhagic fever","volume":"35","author":"MC Weissenbacher","year":"1982","journal-title":"Infect Immun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jmv.1890290312","article-title":"Formalin inactivated Junin virus: immunogenicity and protection assays","volume":"29","author":"C Videla","year":"1989","journal-title":"J Med Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1099\/0022-1317-81-5-1273","article-title":"Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs","volume":"81","author":"N Lopez","year":"2000","journal-title":"J Gen Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0168-1656(99)00122-4","article-title":"Lassa fever: implications of T-cell immunity for vaccine development","volume":"73","author":"J ter Meulen","year":"1999","journal-title":"J Biotechnol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/CDLI.12.10.1223-1230.2005","article-title":"Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice","volume":"12","author":"A Boesen","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1128\/JVI.00896-06","article-title":"Identification of protective Lassa virus epitopes that are restricted by HLA-A2","volume":"80","author":"J Botten","year":"2006","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/28860","article-title":"Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes","volume":"394","author":"P Klenerman","year":"1998","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1128\/JVI.67.6.3497-3506.1993","article-title":"Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus","volume":"67","author":"VJ La Posta","year":"1993","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1128\/JVI.75.14.6273-6278.2001","article-title":"Common antiviral cytotoxic t-lymphocyte epitope for diverse arenaviruses","volume":"75","author":"MB Oldstone","year":"2001","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2003.12.013","article-title":"Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones","volume":"321","author":"J Meulen","year":"2004","journal-title":"Virology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e1000695","DOI":"10.1371\/journal.ppat.1000695","article-title":"A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease","volume":"5","author":"MF Kotturi","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"9947","DOI":"10.1128\/JVI.00672-10","article-title":"A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans","volume":"84","author":"J Botten","year":"2010","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1128\/JVI.02524-08","article-title":"Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection","volume":"83","author":"JN Blattman","year":"2009","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1128\/JVI.00166-11","article-title":"Vaccination alters the balance between protective immunity, exhaustion, escape, and death in chronic infections","volume":"85","author":"PL Johnson","year":"2011","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"10404","DOI":"10.1128\/JVI.00856-11","article-title":"The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain","volume":"85","author":"CG Albarino","year":"2011","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward Jenner and the history of smallpox and vaccination","volume":"18","author":"S Riedel","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref38","first-page":"77","article-title":"The yellow fever vaccine: a history","volume":"83","author":"JG Frierson","year":"2010","journal-title":"Yale J Biol Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"JD Miller","year":"2008","journal-title":"Immunity"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/infdis\/146.3.360","article-title":"Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus","volume":"146","author":"DH Walker","year":"1982","journal-title":"J Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4269\/ajtmh.1985.34.999","article-title":"Kinetic study of platelets and fibrinogen in Lassa virus-infected monkeys and early pathologic events in Mopeia virus-infected monkeys","volume":"34","author":"JV Lange","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0042-6822(92)90514-P","article-title":"Generation of reassortants between African arenaviruses","volume":"188","author":"IS Lukashevich","year":"1992","journal-title":"Virology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"IS Lukashevich","year":"2005","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1016\/j.vaccine.2008.07.057","article-title":"Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates","volume":"26","author":"IS Lukashevich","year":"2008","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11262-006-0050-3","article-title":"Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses","volume":"34","author":"DA Moshkoff","year":"2007","journal-title":"Virus Genes"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1743-422X-7-279","article-title":"Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever","volume":"7","author":"LM Branco","year":"2010","journal-title":"Virol J"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890370102","article-title":"Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys","volume":"37","author":"JB McCormick","year":"1992","journal-title":"J Med Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/nm.2763","article-title":"Development of a new hydrogen peroxide-based vaccine platform","volume":"18","author":"IJ Amanna","year":"2012","journal-title":"Nat Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0264-410X(99)00439-9","article-title":"Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein","volume":"18","author":"M Djavani","year":"2000","journal-title":"Vaccine"},{"key":"ref50","first-page":"103","article-title":"Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus","volume":"4","author":"M Djavani","year":"2001","journal-title":"J Hum Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","article-title":"Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene","volume":"81","author":"TJ Wiktor","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.79.23.7415","article-title":"Vaccinia virus: a selectable eukaryotic cloning and expression vector","volume":"79","author":"M Mackett","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0092-8674(81)90447-5","article-title":"Expression of SV40 T antigen under control of adenovirus promoters","volume":"23","author":"C Thummel","year":"1981","journal-title":"Cell"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nm.2104","article-title":"Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity","volume":"16","author":"L Flatz","year":"2010","journal-title":"Nat Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e18995","DOI":"10.1371\/journal.pone.0018995","article-title":"A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus","volume":"6","author":"BE Martina","year":"2011","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/eji.200737660","article-title":"Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania","volume":"38","author":"B Dondji","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(87)90767-7","article-title":"Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever","volume":"2","author":"JC Clegg","year":"1987","journal-title":"Lancet"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0168-1702(88)90033-0","article-title":"Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection","volume":"9","author":"DD Auperin","year":"1988","journal-title":"Virus Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","article-title":"Effective vaccine for lassa fever","volume":"74","author":"SP Fisher-Hoch","year":"2000","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"M Garbutt","year":"2004","journal-title":"J Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"TW Geisbert","year":"2005","journal-title":"PLoS Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"S785","DOI":"10.1093\/infdis\/jir298","article-title":"Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany","volume":"204 Suppl 3","author":"S Gunther","year":"2011","journal-title":"J Infect Dis"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"B Guy","year":"2010","journal-title":"Vaccine"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.vaccine.2010.11.079","article-title":"Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs","volume":"29","author":"X Jiang","year":"2011","journal-title":"Vaccine"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","article-title":"A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins","volume":"345","author":"PJ Bredenbeek","year":"2006","journal-title":"Virology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"P Pushko","year":"2001","journal-title":"J Virol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1128\/JVI.00560-08","article-title":"Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses","volume":"82","author":"JM Rojek","year":"2008","journal-title":"J Virol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.micinf.2005.03.010","article-title":"Plasmid DNA vaccination","volume":"7","author":"K Huygen","year":"2005","journal-title":"Microbes Infect"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virol.2005.01.019","article-title":"Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein","volume":"335","author":"MP Rodriguez-Carreno","year":"2005","journal-title":"Virology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"JB McCormick","year":"1987","journal-title":"J Infect Dis"},{"key":"ref71","unstructured":"The World Bank (2012) Gross domestic product ranking table 2011. World development indicators. Washington: The World Bank. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/data.worldbank.org\/data-catalog\/http:\/\/databank.worldbank.org\/databank\/download\/GDP.pdf\" xlink:type=\"simple\">http:\/\/data.worldbank.org\/data-catalog\/http:\/\/databank.worldbank.org\/databank\/download\/GDP.pdf<\/ext-link>."},{"key":"ref72","unstructured":"OPEC (2013) Market indicators as at end: December 2012. OPEC market indicators. Vienna: Organization of the Petroleum Exporting Countries. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.opec.org\/opec_web\/static_files_project\/media\/downloads\/data_graphs\/MI122012.pdf\" xlink:type=\"simple\">http:\/\/www.opec.org\/opec_web\/static_files_project\/media\/downloads\/data_graphs\/MI122012.pdf<\/ext-link>."},{"key":"ref73","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/155.3.456","article-title":"Clinical virology of Lassa fever in hospitalized patients","volume":"155","author":"KM Johnson","year":"1987","journal-title":"J Infect Dis"},{"key":"ref74","first-page":"443","article-title":"Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection","volume":"2","author":"JA Streeton","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.2012.11-0525","article-title":"The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review","volume":"86","author":"RE Thomas","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1128\/JVI.02063-06","article-title":"HLA-A2-restricted protection against lethal lymphocytic choriomeningitis","volume":"81","author":"J Botten","year":"2007","journal-title":"J Virol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"11770","DOI":"10.1128\/JVI.05477-11","article-title":"Human CD8(+) and CD4(+) T cell memory to lymphocytic choriomeningitis virus infection","volume":"85","author":"MF Kotturi","year":"2011","journal-title":"J Virol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1745-7580-6-4","article-title":"Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage","volume":"6","author":"MF Kotturi","year":"2010","journal-title":"Immunome Res"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/JVI.74.5.2186-2192.2000","article-title":"Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein","volume":"74","author":"J ter Meulen","year":"2000","journal-title":"J Virol"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T07:49:58Z","timestamp":1595663398000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003212"}},"subtitle":[],"editor":[{"given":"Tom C.","family":"Hobman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,11]]},"references-count":79,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003212","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,11]]}}}